Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BLACK ROCK COFFEE BAR, INC. (BRCB)

  • Business News
  • June 26, 2026, 12:00 UTC
  • 2
  • 1 comments

Black Rock Coffee Bar Expands Footprint in Austin with Georgetown Location

Market reaction Comment Full text

MARQETA, INC. (MQ)

  • Business News
  • June 26, 2026, 12:00 UTC
  • 2
  • 1 comments

Marqeta to Announce Second Quarter 2026 Results on August 4, 2026

Market reaction Comment Full text

EVERLERT, INC. (EVLI)

  • Business News
  • June 26, 2026, 12:00 UTC
  • 5
  • 1 comments

Everlert, Inc. (OTC: EVLI), Operating as American Gold & Copper Inc., Signs Memorandum of Understanding for Proposed Acquisition of the Rimrock Copper-Gold Project in Nevada

Market reaction Comment Full text

CINEVERSE CORP. (CNVS)

  • Business News
  • June 26, 2026, 12:00 UTC
  • 2
  • 1 comments

Cineverse Reports Fourth Quarter and Fiscal Year 2026 Results

Market reaction Comment Full text

ABBVIE INC. (ABBV)

  • Business News
  • June 26, 2026, 12:00 UTC
  • 3
  • 1 comments

AbbVie to Host Second-Quarter 2026 Earnings Conference Call

Market reaction Comment Full text

TKO GROUP HOLDINGS, INC. (TKO)

  • Business News
  • June 26, 2026, 12:00 UTC
  • 4
  • 1 comments

UFC® Freedom 250 Delivers 34 Million Total Global Viewers

Market reaction Comment Full text

ROCKET COMPANIES, INC. (RKT)

  • Business News
  • June 26, 2026, 12:00 UTC
  • 4
  • 1 comments

Americans Across Party Lines Back Policies to Improve Housing Affordability: Redfin Survey

Market reaction Comment Full text

XCHG LTD (XCH)

  • Business News
  • June 26, 2026, 12:00 UTC
  • 4
  • 1 comments

XCharge Announces Pricing of $4.375 Million Registered Direct Offering with a Single Global Institutional Investor

Market reaction Comment Full text

MAINZ BIOMED N.V. (QUCY)

  • Business News
  • June 26, 2026, 12:00 UTC
  • 4
  • 1 comments

Quantum Cyber Approves Acquisition of Equity Stake in SpaceX

Market reaction Comment Full text

Ensysce Biosciences Inc. (ENSC)

  • Business News
  • June 26, 2026, 12:00 UTC
  • 2
  • 1 comments

Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study

Market reaction Comment Full text
  • Previous
  • 3372
  • 3373
  • 3374
  • 3375
  • 3376
  • Next

Search

News categories

  • Technical Exchange News(14539)
  • Event(6229)
  • SEC News(383618)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(234507)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin